Nestlé Health Science (NHSc), a Nestlé subsidiary focused on nutritional science, has agreed to acquire a majority stake in Vital Proteins, a US collagen brand offering supplements, beverages and food products.
The transaction, which makes Vital Proteins part of the Nestlé Health Science portfolio, is expected to be closed subject to regulatory approvals. The deal will benefit Vital Proteins with a variety of resources to scale their reach.
NHSc CEO Greg Behar said: “This is an exciting opportunity for Nestlé Health Science to enter a growing area of nutrition with a successful brand.
“Our companies share the belief that nothing is more important than health, and everything we do is focused on that belief. In combining our efforts to optimize health through nutrition, we can achieve even more to help our consumers live fuller, more vibrant lives.”
Vital Proteins will complement Nestlé Health Science’s vitamin, mineral, supplement and wellness brands
Under the terms of the transaction, Vital Proteins is planned to operate as a standalone business, continuing its sustainably-sourced collagen nutrition offering.
Vital Proteins founder and CEO Kurt Seidensticker will continue to leading the company as CEO, operating from its headquarters in Chicago, Illinois.
The company claimed that it will complement NHSc’s other vitamin, mineral, supplement and wellness brands, including Atrium Innovations, Garden of Life, Pure Encapsulations and Persona.
Established in 2013, Vital Proteins offers a variety of collagen products to supplement, vitamin, food and beverage categories, and offers an assortment of options for consumers.
Seidensticker said: “We at Vital Proteins, alongside Nestlé Health Science, are committed to expanding our wellness platform to the world.
“We are partnering together to continue the evolution of the functional nutrition space through premium products and innovation that meet customers where they are in their wellness journey.
“Joining NHSc allows us to take Vital Proteins to the next level by leveraging resources, scale and capabilities, and moving toward a future with an expanded offering of science-backed products.”
